Price T Rowe Associates Inc Neogenomics Inc Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 645,492 shares of NEO stock, worth $8.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

645,492

Previous 640,964 0.71%

Holding current value

$8.86 Million

Previous $10.4 Million 2.16%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$14.06 - $16.79 $63,663 - $76,025	4,528 Added 0.71%	645,492 $10.1 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $548,104 - $973,625	46,967 Added 7.91%	640,964 $10.4 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $137,404 - $201,865	11,309 Added 1.94%	593,997 $7.31 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $3.57 Million - $5.02 Million	252,988 Added 76.73%	582,688 $9.37 Million
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $12,344 - $26,413	1,358 Added 0.41%	329,700 $5.74 Million

Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $2.58 Million - $4.82 Million	-399,246 Reduced 54.87%	328,342 $3.03 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $6.64 Million - $10.9 Million	-844,425 Reduced 53.72%	727,588 $6.27 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $35,836 - $70,911	5,076 Added 0.32%	1,572,013 $12.8 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $202,358 - $587,588	16,655 Added 1.07%	1,566,937 $19 Million
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $37,197 - $59,157	-1,220 Reduced 0.08%	1,550,282 $52.9 Million
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $314,324 - $396,263	-7,545 Reduced 0.48%	1,551,502 $74.8 Million
Q2 2021 Aug 16, 2021	BUY	$36.62 - $51.69 $249,418 - $352,060	6,811 Added 0.44%	1,559,047 $70.4 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $7.89 Million - $11.4 Million	189,930 Added 13.94%	1,552,236 $74.9 Million
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $49.2 Million - $76.9 Million	1,362,306 New	1,362,306 $73.3 Million

Others Institutions Holding NEO

# of Institutions

280

Shares Held

128M

Call Options Held

1.13M

Put Options Held

232K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.73B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Neogenomics Inc Transaction History